Top Markets
Coin of the day
Eikon Therapeutics, Inc. Common Stock Eikon Therapeutics, Inc. Common Stock

Eikon Therapeutics, Inc. Common Stock

EIKN
Rang in aandelen #12325
Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established... Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing protein interactions inside living cells. Eikon's drug pipeline includes EIK1001, a systemically delivered TLR 7/8 dual-agonist designed to activate both innate and adaptive anti-cancer immune responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors for ovarian, breast, prostate, and pancreatic cancers. Notably, EIK1004 is brain-penetrant, offering a therapeutic approach for brain metastases and primary brain malignancies. Additionally, EIK1005 is a potent WRN helicase inhibitor and anti-tumor agent aimed at MSI-high tumors, alongside EIK1006.
Aandeelprijs
$11.03
Laatst gesynchroniseerd: 2026-08-28
Marktkapitalisatie
$597.15M
Verandering (1 dag)
-4.25%
Verandering (1 jaar)
-
Land
US
Handel Eikon Therapeutics, Inc. Common Stock (EIKN)

Categorie

Koersgeschiedenis voor Eikon Therapeutics, Inc. Common Stock (EIKN)
Hoogste slotkoers: $10.87 op 2026-08-01

Laagste slotkoers: $14.75 op 2026-02-01
Koersgeschiedenis van Eikon Therapeutics, Inc. Common Stock van 2026 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
Niet genoeg gegevens voor de verstrekte datums.
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$542.09 38.63%
US
$1.03K 44.13%
NL
$120.75 -13.26%
AU
$138.18 473.58%
US
$759.27 7.20%
CH